Topic Archives: glioblastoma

[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends.  He does not typically write about specific investment opportunities, but has agreed to our trading restrictions… as with all of our authors, […]

Comments

  • Medicenna is exciting for the fact that they seem to have a treatment glioblastoma. I lost a good friend to it years ago...

  • Yes the covid-19 vaccine race is definitely a bubble similar to the latest weed bubble not too long ago. However, if I ...

  • In regards to Glioblastoma NWBO, deep in OTC penny land, is hopefully close to P3 results. Anecdotal comments suggest ...

  • $DFFN UW CHARLOTTESVILLE, Va., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq:DFFN) (Diffu...

  • $DFFN bid os - https://finviz.com/quote.ashx?t=DFFN #Diffusio2n http://www.diffusionpharma.com/scientific-advisory-boar...

  • $DMPI LONG 29-Dec-2017:08:43:00, DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent G...

  • $DPMI 26-Dec-2017:05:30:00, DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblas...

  • $VBLT np - New Biomarker Data Supports Direct Link between VB-111’s Dual Mechanism of Action and its Clinical Effect o...

  • $MBRX 1/2p - Please be advised, the Moleculin Biotech, Inc. (Nasdaq: MBRX) management team including, Walter Klemp, CE...

  • $TRIL - Society for Neuro-Oncology 22nd Annual Meeting poster: http://s2.q4cdn.com/772010778/files/doc_presentations/20...

  • $STML LONG NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage b...

  • $ STML Long More News 09-Nov-2017:16:01:00, Stemline Therapeutics Reports Third Quarter 2017 Financial Result...

  • $TRIL - November 18, 2017 05:00 PM PST San Francisco, CA Presenter: Zezhou Wang, Ph.D., Trillium Research Scientist h...

  • NP $ VBLT 07:01 VBLT Vascular Biogenics announces that the EMA has designated ofranergene obadenovec (VB-11...

  • NP $ MBRX heflyonthewall.com: Moleculin announces strategic collaboration to develop immune stimulation drug Molec...

  • Michael, Why have you not discussed the phase 3 results of Northwest Bio on the most deadly form of glioblastoma?...

  • $ABIO and others Thx Levbrans. Re: ABIO. I have a morbidly obese position with avg price of 2.00, so I'm down about 30...

  • $ABIO $BLPH $VBLT Just added heavily to all 3 positions and now OW. ABIO: Briefly, they are developing the Beta ...

  • $VBLT. Thanks, Doc. To be clear about this, I'm not questioning your medical knowledge or investment advice, both of...

  • vanderwall7, you said there has never been a cure of a glioblastoma multiforma tumor. I've been following a doctor in Ho...

  • There has been a glioblastoma multiforma that was held in remission for 5 years, using a low-temperature water extract o...

  • One of the example he used was a GBM that went into remission. To my knowledge there has never been a cure of a GBM whi...

  • $VBLT - 2 conference presentations: http://ir.vblrx.com/phoenix.zhtml?c=253311&p=irol-news&nyo=0 2017 BIO ...

  • $ VBLT. Long VBL Therapeutics announces VB-111 phase 2 data presented at ASCO VBL Therapeutics announced the present...

  • $VBLT Doc, here is a transcript of their CC from 2 days ago. Still looking good IMO. Re: Their GBM, they expect in...

  • $CLRB long Shares down on (despite?) patent news: Apr 25, 2017: Cellectar Biosciences Receives Additional U.S. Patent...

  • $VBLT VBL Therapeutics Announces Upcoming Presentations on VB-111 at the ASCO and ASGCT 2017 Conferences - TEL AVI...

  • $ VBLT Long 20-Apr-2017:16:01:00, VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigat...

  • $AGEN np - Agenus’ lead cancer vaccine flops, investigators read last rites over glioblastoma PhII $AGEN -5.5% https:...

  • $STML: Stemline Therapeutics Provides Update on Clinical Programs SL-401 --Patient enrollment has continued to...

  • Revolutionary approach for treating glioblastoma works with human cells News Release: For immediate use: Revolutionary...

  • Hi everyone, According to the trusted source: @AndyBiotech $TCON will soon release their TRC105 & Avastin 1012 mont...

  • $VBLT: VBL Therapeutics Announces Completion of Enrollment in the Pivotal GLOBE Study January 6, 2017 TEL AVIV, I...

  • Berberine. Here is what I found at LEF.Com. Berberine is an alkaloid found in various different medicinal herbs. Prob...

  • DB: that was among my very first questions in picking through what I CAN access on NSI-189. Some of it is proprietary, B...

  • $CUR I was just looking at that stock and was a little bit concerned about the possibility of causing other neural tissu...

  • $STML long - Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at t...

  • $AGEN: Agenus Reports Third Quarter Financial Results and Recent Highlights/Development Updates Company to host conf...

  • From a quick read, their focus is totally different. These are the two treatments they are actively pursuing: 1. Brai...

  • The most devastating aspect of $BMY's "epic failure" was that, in the trial for NSCLC as front-line therapy, Opdivo fail...

  • ben Thank you . That makes eminent sense to me and is quite astounding that such a small sample may yield results. This ...

  • $VBLT -- Dr. KSS: On June 10, you said "Biggest problem is that it can only be given once" (in context of glioblastoma...

  • $VBLT is VBL Technologies, formerly Vascular Biogenics, an Israeli firm. I took a position because I was impressed with ...

  • Dr KSS I don't know if you have seen this ,,,It seems to me this is worth noting on brain barrier crossing. The blood-b...

  • $KPTI nada - Karyopharm to Present Selinexor Clinical Data at the American Society of Clinical Oncology Annual Meeting ...

  • As to the discussion of Duke's modified poliovirus for glioblastoma multiforme, as best I can tell this study or its IP ...

  • Make that three of us. I added to my modest position yesterday. Also loved the study Glenn shared about efforts to cross...

  • glenn Thanks for this post. My youngest son died of glioblastoma in his late forties....

  • $KPTI From Bens link, it does look promising for Selinexor. Unfortunately I opened my full position at the peak (~$30...

  • Glioblastoma is a bad dz, usually not much after 6 months of dx people were dead. This has improved some. Gamma knife us...

  • AGEN, AKBA, PIRS, FLKS: Extracted from: http://www.thelifesciencesreport.com/pub/na/panelists-select-19-companies-for-t...

  • Getting a gut feeling that AGEN is sitting on some great news coming with several strong catalysts coming into play. The...

  • Phase 2 Study of MEDI4736 in Patients With Glioblastoma https://clinicaltrials.gov/ct2/show/study/NCT02336165?term=MEDI...

  • NVCR- FDA Approves Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma http://...

  • I entered Agenus $AGEN this past week. Since we now have evidence of efficacy on multiple fronts---genital herpes, sh...

  • OK, I will honorably concede a certain measure of defeat as regards $CLDX. Its immune-tweaking agent rindopepimut, combi...

  • $KPTI: Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) in Solid Tumors - Presentation to Include ...

  • $KPTI. from leerink asco abstracts. • KPTI (OP): Ph II data for selinexor suggests single agent activity in solid...

  • Karyopharm (KPTI) presenting solid tumor data on Selinxor at ASCO. Promising antitumor activity was observed in abstrac...

  • $ZIOP: Ziopharm initiates Phase 1 gene therapy trial in brain cancer -Ziopharm Oncology (NASDAQ:ZIOP) commences a Ph...

  • Ok this does come from SA but it was very interesting nonetheless. It looks to be similar to Cellectis. http://seekin...

  • $CLDX up 15% this morning based on this FDA granting rindopepimut (Rintega(R)) Breakthrough Therapy Designation for the ...

  • Ok that "global stomp" in my last post should say glioblastoma! Damn auto correct!...

  • Even with a CAR-T-entrained approach against the mutant EGF regions typifying glioblastoma multiforme, anti-tumor respon...

  • Hi edinle....$CLDX has come up several times in the threads, but to summarize: (1) I predict phase 3 failure for rind...

  • Doc, If you have time, could you give us an opinion about CLDX. The pipeline includes rindopepimut, in P3 trials for gl...

  • Northwest Biotherapeutic (NWBO) might deserve a mention in this list. NW Bio is Developing dendritic cell-based vaccines...

  • Glenn, I think you asked earlier about Northwest Biotherapeutics and its dendritic cell vaccine program for glioblastoma...

  • Janus Associated Kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3) for myleodysplasia, old blood. They have competit...

  • Hello Dr K, according to their website this method/device already has FDA approval for and is already in use for re-cur...

  • NEVER AGAIN IN THIS INCARNATION WILL YOU SEE THIS HAPPEN: a phase 3 trial for glioblastoma stopped early on unprecedent...

  • Kenny: I don't mean to ruffle any feathers, but I am of little or no faith in $CLDX. Its glioblastoma program themed ...

  • I had no idea so many companies are working on so many drugs. Are all of them private companies except ISIS? ISIS: ...

  • Some great news from AEMD dealing with brain cancer: Aethlon Medical and Exosome Sciences Expand Brain Research Disco...

  • This is an interesting experiment, Travis. I have two specs that I am currently playing. One is Northwest Biotherapeut...

  • Siva: I don't mean to sound like the Herb Greenberg of Gumshoe, but I just cannot see a case for IMUC at all. It issued ...

  • Found this Seeking Alpha article today about Celldex and its glioblastoma vaccine (which includes Stellar's KLH), could...

  • Thanks for the reply AH. I used the lower range of numbers that Stellar estimated (in their investor presentation) as y...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info